This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ethris Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Petra Pennekamp - Innovator in Ciliopathy Treatment
Introduction
Petra Pennekamp is a notable inventor based in Münster, Germany. She is currently associated with Ethris GmbH, where she focuses on innovative solutions for medical challenges. With a keen interest in the treatment of ciliopathies, her work aims to improve the lives of those affected by these conditions.
Latest Patent Applications
Petra Pennekamp has made significant strides in her field, particularly with her patent application titled "Treatment of Ciliopathies." This application presents a pharmaceutical composition that includes a polyribonucleotide designed to treat ciliopathies in affected subjects. The composition encodes a functional version of a protein whose defect is linked to the ciliopathy. Furthermore, the application outlines a method for analyzing the effects of the polyribonucleotide on ciliogenesis, which is crucial for understanding and potentially mitigating the effects of these disorders.
Conclusion
Petra Pennekamp's contributions to the field of medical innovation, particularly in the treatment of ciliopathies, highlight her dedication to advancing healthcare solutions. Her work at Ethris GmbH and her ongoing research reflect her commitment to improving patient outcomes through innovative therapies.